| Identification | Back Directory | [Name]
MEN 10208 | [CAS]
129781-07-3 | [Synonyms]
MEN 10208
[Tyr5,D-Trp6,8,9,Arg10]NKA(3-10)
Thr-asp-tyr-trp-val-trp-trp-arg-NH2
Thr-Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Arg-NH2
[Tyr5,D-Trp6,8,9,Arg10]neurokinin A(3-10)
L-Thr-L-Asp-L-Tyr-D-Trp-L-Val-D-Trp-D-Trp-L-Arg-NH2 | [Molecular Formula]
C61H75N15O12 | [MOL File]
129781-07-3.mol | [Molecular Weight]
1210.34 |
| Hazard Information | Back Directory | [Description]
Men 10208 is a neurokinin A receptor antagonist. | [Uses]
MEN 10208 is a neurokinin A antagonist prepared by solid phase synthesis. The Fmoc strategy has more advantages than the Boc strategy in its preparation, and can obtain products with higher yield and purity. | [References]
[1] Solid-phase synthesis of neurokinin A antagonists. Comparison of the Boc and Fmoc methods PMID:1850390 |
|
|